Developer docs
API playgroundTry for free, no card

Search company profiles

Fortis Life Sciences

Full company profile

uuid00064jb

Namestring
Fortis Life Sciences
Legal namestring
Fortis Life Sciences
Websiteurl
fortislife.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Fortis Life Sciences is a private, US-domiciled life sciences reagents and diagnostics platform that aggregates multiple specialized brands under a unified 'One Fortis' umbrella. Its wholly-owned subsidiaries — Bethyl Laboratories (recombinant monoclonal antibodies), nanoComposix (engineered nanoparticles), Abcore (antibody development, VHH libraries), Vector Biolabs (viral vectors for gene delivery and CAR-T/CAR-NK research), Arista Biologicals (lateral flow infectious disease reagents), Empirical Bioscience (molecular biology enzymes and master mixes), and IPOC (life sciences reagents) — together supply antibodies, antigens, ELISA and Western Blot detection kits, IHC reagents, lateral flow components, nanoparticles, viral vectors, and VHH single-domain antibody libraries including the AbNano® platform.

The company monetizes through three streams: product sales (catalog research and diagnostic components), custom services (antibody development and manufacturing, viral vector services, diagnostic CDMO manufacturing, spatial biology multiplex imaging), and bulk/OEM supply for diagnostic kit manufacturers. Manufacturing and R&D are anchored in three ISO 13485-certified and GMP-compliant North American sites, with commercial reach delivered via a distributor network spanning 60+ countries across North America, South America, Europe, Asia, Africa, Oceania, and the Middle East.

Customers are organized across four vertical segments — research institutions, diagnostics manufacturers, biopharmaceutical companies, and applied technology companies — with pricing structured as quote-based B2B contracts across reagent SKUs, OEM partnerships, and service engagements. Differentiation rests on proprietary assets (AbNano® VHH libraries, 'Six Pillars of Antibody Validation'), the Farm-to-Bench integrated supply chain, regulatory certifications, and the consolidated multi-brand portfolio that lets customers source antibodies, nanoparticles, viral vectors, and diagnostic components from a single supplier.

Short descriptiontext

Fortis Life Sciences is a private US-based life sciences reagent and diagnostics platform that aggregates specialized brands (Bethyl, nanoComposix, Abcore, Vector Biolabs, Arista, Empirical, IPOC) to supply antibodies, nanoparticles, viral vectors, VHH libraries, and diagnostic components to research institutions, diagnostic manufacturers, biopharma, and applied tech customers across 60+ countries via three ISO 13485/GMP manufacturing sites.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science reagents, diagnostic components, antibody development services, viral vector manufacturing, lateral flow assays
Industry4 codes
1HLAGAIAI
CodeHLAGAIAIPrimaryYes
2HLAAAIAB
CodeHLAAAIABPrimaryNo
3HLAAACAJ
CodeHLAAACAJPrimaryNo
4HLAGABAC
CodeHLAGABACPrimaryNo
NAICS code3 codes
  • 325413
  • 325414
  • 541714
SIC code3 codes
  • 2835
  • 2836
  • 8731
Product category
Life Sciences Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales
TypeOne Time License
Description

Sale of life science reagents including antibodies, antigens, ELISA kits, western blot antibodies, IHC reagents, enzymes, nanoparticles, viral vectors, and diagnostic components

fortislife.com
2Custom Services
TypeProfessional Services
Description

Antibody development and manufacturing services, viral vector services, diagnostic CDMO manufacturing, spatial biology multiplex imaging services

fortislife.com
3Bulk & OEM Supply
TypeHardware Sales
Description

Bulk reagent supply and OEM manufacturing for diagnostic kit manufacturers

fortislife.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AbNano
Description

VHH single-domain antibody libraries and discovery services for challenging targets including NK cell and T-cell programs

fortislife.com
+2 more records
Core offering1 text field

Fortis Life Sciences manufactures and supplies life science reagents and diagnostic components, including antibodies, antigens, ELISA kits, Western blot and IHC antibodies, clinical immunology reagents, enzymes, master mixes, lateral flow assay reagents, engineered nanoparticles, VHH single-domain antibody libraries, and viral vectors. The company also provides custom services spanning antibody development and manufacturing, diagnostic CDMO manufacturing, and spatial biology multiplex imaging, serving biopharma, diagnostics, research, and applied technology customers across 60+ countries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Fortis Life Sciences operates as a diversified life sciences reagents and diagnostics company that aggregates multiple specialized brands under a unified platform. The company offers a comprehensive portfolio spanning antibodies and antigens, assays and kits, bulk and OEM reagents, diagnostic components, enzymes and master mixes, lateral flow reagents, engineered nanoparticles, VHH single-domain antibody libraries, and viral vectors. Key product lines include Bethyl recombinant monoclonal antibodies, AbNano® VHH libraries for antibody discovery, and various immunodetection reagents (ELISA, Western Blot, IHC). The company provides associated services including antibody development and manufacturing, diagnostic CDMO manufacturing, and spatial biology imaging services. Fortis positions itself as a 'One Fortis' unified platform that integrates specialized expertise across critical reagents, technologies, and expertise for the life sciences and diagnostics industries.

Product and service18 records
1ELISA Detection Kits
CategoryImmunodetection Reagents
Description

Secondary antibodies and immunoglobulin detection reagents used in quantitative ELISA applications for scientific research.

2Western Blot Detection Antibodies
CategoryImmunodetection Reagents
Description

Secondary antibodies designed for sensitive protein detection and signal amplification in western blot applications.

3Immunohistochemistry Reagents
CategoryImmunodetection Reagents
Description

Antibodies used in tissue-based immunodetection and pathology workflows for research applications.

4Clinical Immunology Reagents
CategoryDiagnostic Reagents
Description

Antibodies targeting immunoglobulins, isotypes, and related epitopes for research and clinical immunology applications.

5Bethyl Recombinant Monoclonal Antibodies
CategoryAntibodies
Description

Recombinant monoclonal antibodies from Bethyl Laboratories for immunodetection applications including IHC, Western Blot, ICC, and IP.

6AbNano VHH Anti-NK-Cell Library
CategoryVHH Antibody Libraries
Description

First-in-class peripheral NK cell-derived VHH single-domain antibody library designed for NK target discovery, CAR-NK research, and advanced screening workflows, with optional discovery services.

7VHH Libraries
CategoryVHH Antibody Libraries
Description

Single-domain antibody (VHH) libraries including naive libraries and cell-specific libraries for antibody discovery.

8Nanoparticles
CategoryNanoparticles
Description

Engineered nanoparticles including gold nanoshells, nanorods, iron oxide, and mesoporous silica for research and diagnostic applications.

9Viral Vectors
CategoryViral Vectors
Description

Viral vector platforms and services for gene delivery and cell therapy research, supporting gene delivery and CAR-T/CAR-NK research programs.

10Lateral Flow Reagents
CategoryDiagnostic Reagents
Description

Reagents for lateral flow assay development including antibodies and antigens.

11Arista Biologicals West Nile Virus LFA Reagents
CategoryDiagnostic Reagents
Description

Lateral flow assay reagents for infectious disease detection, including West Nile Virus antigens for diagnostic kit manufacturing.

12Enzymes and Master Mixes
CategoryMolecular Biology Reagents
Description

Molecular biology enzymes and pre-formulated master mixes for various assay applications.

13Assays and Kits
CategoryAssays and Kits
Description

Ready-to-use assay kits for various research applications.

14Diagnostic Components
CategoryDiagnostic Components
Description

Components for diagnostic kit manufacturing including antibodies and reagents.

15Bulk and OEM Reagent Supply
CategoryBulk and OEM Supply
Description

Bulk reagent supply and original equipment manufacturing services for commercial and industrial applications.

16Antibody Development and Manufacturing Services
CategoryContract Services
Description

Full-service antibody development including discovery, engineering, and GMP manufacturing for research and diagnostic applications, including Farm-to-Bench custom recombinant antibody development services.

17Diagnostic CDMO Manufacturing Services
CategoryContract Manufacturing Services
Description

Contract development and manufacturing organization services for diagnostic products including lyophilization and assay development.

18Spatial Biology Multiplex Imaging Services
CategoryResearch Services
Description

Multiplex imaging services for tumor microenvironment profiling and spatial biology research.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

Primary antibody supplier partner specializing in immunodetection reagents including ELISA kits, western blot antibodies, and immunohistochemistry reagents. Bethyl provides validated antibodies used in Fortis product catalog.

Strategic tierCoreTypeTechnology or Integration
Description

Nanoparticle supplier providing gold nanoshells, gold nanorods, gold colloid, iron oxide nanoparticles, PLGA nanoparticles, and mesoporous silica nanoparticles for research and diagnostic applications.

Strategic tierCoreTypeTechnology or Integration
Description

Antibody supplier partner integrated into Fortis product offerings for immunodetection reagents.

Strategic tierCoreTypeTechnology or Integration
Description

Supplier of infectious disease lateral flow assay reagents including West Nile Virus antigens for diagnostic kit manufacturing.

Strategic tierCoreTypeTechnology or Integration
Description

Viral vector supplier providing products and services for gene delivery and CAR-T/CAR-NK research programs.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Life sciences services and reagents company offering custom antibody development, recombinant proteins, gene synthesis, and CDMO services — directly comparable to Fortis's antibody development/manufacturing services and AbNano VHH library offerings.

TypeBroad incumbent
Description

Diversified life sciences and diagnostics conglomerate housing Abcam, Cytiva, Beckman Coulter, Leica Biosystems, and Cepheid — competes with Fortis through its antibody subsidiary (Abcam) and across diagnostic reagent/CDMO adjacencies, with vastly greater resources and breadth.

TypeDirect peer
Description

Pure-play antibody supplier with a catalog of primary antibodies, conjugates, and immunoassay reagents serving biopharma, academic, and diagnostics customers. Most directly comparable to Fortis's Bethyl/Abcore franchises on product, customer base, and distribution model.

TypeDirect peer
Description

Specialist antibody company focused on validated reagents for signal transduction, immuno-oncology, and IHC/WB applications — closely comparable to the Bethyl recombinant monoclonal antibody portfolio and the Fortis Six Pillars validation methodology positioning.

TypeDirect peer
Description

Life science arm of Merck KGaA offering antibodies, ELISA kits, enzymes, and reagents for research and applied markets — competes with Fortis across nearly every catalog category (antibodies, assay kits, enzymes, lateral-flow reagents).

TypeDirect peer
Description

Recombinant antibody and protein manufacturer serving research, diagnostic, and biopharma customers globally — comparable in catalog breadth across recombinant antibodies/antigens and in supplying bulk/OEM to diagnostic kit manufacturers, similar to Fortis's CDMO and bulk reagent streams.

TypeDirect peer
Description

Global reagents and proteins company with leading antibody (R&D Systems, Novus Biologicals), ELISA, and proteomics franchises — directly competes with Fortis/Bethyl/Abcore in research-grade antibodies and assay kits, and shares the CDMO-adjacent reagent value proposition.

TypeDirect peer
Description

Long-standing research antibody supplier with broad primary and secondary antibody coverage for WB, IHC, IP, and ICC — competes head-to-head with Fortis/Bethyl/Abcore in academic and applied-research reagent purchasing.

TypeBroad incumbent
Description

Largest life sciences tools incumbent offering antibodies (Invitrogen), ELISA, enzymes, viral vectors, and diagnostic manufacturing services through its Patheon CDMO franchise — overlaps Fortis across both product catalog and CDMO services but at much greater scale and breadth.

TypeDirect peer
Description

Privately held antibody and immunoassay reagent supplier offering custom antibody development and OEM diagnostic reagents — closely comparable in product mix (WB/IHC antibodies, ELISA, OEM supply) and in target customer base of academic and diagnostic-OEM accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fortis Life Sciences

Life Sciences Reagentsfortislife.com

Fortis Life Sciences is a private US-based life sciences reagent and diagnostics platform that aggregates specialized brands (Bethyl, nanoComposix, Abcore, Vector Biolabs, Arista, Empirical, IPOC) to supply antibodies, nanoparticles, viral vectors, VHH libraries, and diagnostic components to research institutions, diagnostic manufacturers, biopharma, and applied tech customers across 60+ countries via three ISO 13485/GMP manufacturing sites.

What Fortis Life Sciences does

Fortis Life Sciences is a private, US-domiciled life sciences reagents and diagnostics platform that aggregates multiple specialized brands under a unified 'One Fortis' umbrella. Its wholly-owned subsidiaries — Bethyl Laboratories (recombinant monoclonal antibodies), nanoComposix (engineered nanoparticles), Abcore (antibody development, VHH libraries), Vector Biolabs (viral vectors for gene delivery and CAR-T/CAR-NK research), Arista Biologicals (lateral flow infectious disease reagents), Empirical Bioscience (molecular biology enzymes and master mixes), and IPOC (life sciences reagents) — together supply antibodies, antigens, ELISA and Western Blot detection kits, IHC reagents, lateral flow components, nanoparticles, viral vectors, and VHH single-domain antibody libraries including the AbNano® platform.

The company monetizes through three streams: product sales (catalog research and diagnostic components), custom services (antibody development and manufacturing, viral vector services, diagnostic CDMO manufacturing, spatial biology multiplex imaging), and bulk/OEM supply for diagnostic kit manufacturers. Manufacturing and R&D are anchored in three ISO 13485-certified and GMP-compliant North American sites, with commercial reach delivered via a distributor network spanning 60+ countries across North America, South America, Europe, Asia, Africa, Oceania, and the Middle East.

Customers are organized across four vertical segments — research institutions, diagnostics manufacturers, biopharmaceutical companies, and applied technology companies — with pricing structured as quote-based B2B contracts across reagent SKUs, OEM partnerships, and service engagements. Differentiation rests on proprietary assets (AbNano® VHH libraries, 'Six Pillars of Antibody Validation'), the Farm-to-Bench integrated supply chain, regulatory certifications, and the consolidated multi-brand portfolio that lets customers source antibodies, nanoparticles, viral vectors, and diagnostic components from a single supplier.

Fortis Life Sciences firmographics

Firmographics
Name
Fortis Life Sciences
Legal name
Fortis Life Sciences
Website
https://fortislife.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
Fortis Life Sciences is a private US-based life sciences reagent and diagnostics platform that aggregates specialized brands (Bethyl, nanoComposix, Abcore, Vector Biolabs, Arista, Empirical, IPOC) to supply antibodies, nanoparticles, viral vectors, VHH libraries, and diagnostic components to research institutions, diagnostic manufacturers, biopharma, and applied tech customers across 60+ countries via three ISO 13485/GMP manufacturing sites.
Ownership category
akta.pro rank

Where Fortis Life Sciences is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Fortis Life Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Product Sales: Sale of life science reagents including antibodies, antigens, ELISA kits, western blot antibodies, IHC reagents, enzymes, nanoparticles, viral vectors, and diagnostic components
  2. Custom Services: Antibody development and manufacturing services, viral vector services, diagnostic CDMO manufacturing, spatial biology multiplex imaging services
  3. Bulk & OEM Supply: Bulk reagent supply and OEM manufacturing for diagnostic kit manufacturers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Fortis Life Sciences product offering

Product offering

Core offering

Fortis Life Sciences manufactures and supplies life science reagents and diagnostic components, including antibodies, antigens, ELISA kits, Western blot and IHC antibodies, clinical immunology reagents, enzymes, master mixes, lateral flow assay reagents, engineered nanoparticles, VHH single-domain antibody libraries, and viral vectors. The company also provides custom services spanning antibody development and manufacturing, diagnostic CDMO manufacturing, and spatial biology multiplex imaging, serving biopharma, diagnostics, research, and applied technology customers across 60+ countries.

Product overview

Fortis Life Sciences operates as a diversified life sciences reagents and diagnostics company that aggregates multiple specialized brands under a unified platform. The company offers a comprehensive portfolio spanning antibodies and antigens, assays and kits, bulk and OEM reagents, diagnostic components, enzymes and master mixes, lateral flow reagents, engineered nanoparticles, VHH single-domain antibody libraries, and viral vectors. Key product lines include Bethyl recombinant monoclonal antibodies, AbNano® VHH libraries for antibody discovery, and various immunodetection reagents (ELISA, Western Blot, IHC). The company provides associated services including antibody development and manufacturing, diagnostic CDMO manufacturing, and spatial biology imaging services. Fortis positions itself as a 'One Fortis' unified platform that integrates specialized expertise across critical reagents, technologies, and expertise for the life sciences and diagnostics industries.

Differentiator

Problem solved

Functional benefit

Brands

  • AbNano: VHH single-domain antibody libraries and discovery services for challenging targets including NK cell and T-cell programs
  • Farm-to-Bench
  • Bethyl

Products and services

  • ELISA Detection Kits Secondary antibodies and immunoglobulin detection reagents used in quantitative ELISA applications for scientific research.
  • Western Blot Detection Antibodies Secondary antibodies designed for sensitive protein detection and signal amplification in western blot applications.
  • Immunohistochemistry Reagents Antibodies used in tissue-based immunodetection and pathology workflows for research applications.
  • Clinical Immunology Reagents Antibodies targeting immunoglobulins, isotypes, and related epitopes for research and clinical immunology applications.
  • Bethyl Recombinant Monoclonal Antibodies Recombinant monoclonal antibodies from Bethyl Laboratories for immunodetection applications including IHC, Western Blot, ICC, and IP.
  • AbNano VHH Anti-NK-Cell Library First-in-class peripheral NK cell-derived VHH single-domain antibody library designed for NK target discovery, CAR-NK research, and advanced screening workflows, with optional discovery services.
  • VHH Libraries Single-domain antibody (VHH) libraries including naive libraries and cell-specific libraries for antibody discovery.
  • Nanoparticles Engineered nanoparticles including gold nanoshells, nanorods, iron oxide, and mesoporous silica for research and diagnostic applications.
  • Viral Vectors Viral vector platforms and services for gene delivery and cell therapy research, supporting gene delivery and CAR-T/CAR-NK research programs.
  • Lateral Flow Reagents Reagents for lateral flow assay development including antibodies and antigens.
  • Arista Biologicals West Nile Virus LFA Reagents Lateral flow assay reagents for infectious disease detection, including West Nile Virus antigens for diagnostic kit manufacturing.
  • Enzymes and Master Mixes Molecular biology enzymes and pre-formulated master mixes for various assay applications.
  • Assays and Kits Ready-to-use assay kits for various research applications.
  • Diagnostic Components Components for diagnostic kit manufacturing including antibodies and reagents.
  • Bulk and OEM Reagent Supply Bulk reagent supply and original equipment manufacturing services for commercial and industrial applications.
  • Antibody Development and Manufacturing Services Full-service antibody development including discovery, engineering, and GMP manufacturing for research and diagnostic applications, including Farm-to-Bench custom recombinant antibody development services.
  • Diagnostic CDMO Manufacturing Services Contract development and manufacturing organization services for diagnostic products including lyophilization and assay development.
  • Spatial Biology Multiplex Imaging Services Multiplex imaging services for tumor microenvironment profiling and spatial biology research.

Companies that use Fortis Life Sciences

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Fortis Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Fortis Life Sciences partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Bethyl LaboratoriescoreTechnology or IntegrationPrimary antibody supplier partner specializing in immunodetection reagents including ELISA kits, western blot antibodies, and immunohistochemistry reagents. Bethyl provides validated antibodies used in Fortis product catalog.
  • nanoComposixcoreTechnology or IntegrationNanoparticle supplier providing gold nanoshells, gold nanorods, gold colloid, iron oxide nanoparticles, PLGA nanoparticles, and mesoporous silica nanoparticles for research and diagnostic applications.
  • AbcorecoreTechnology or IntegrationAntibody supplier partner integrated into Fortis product offerings for immunodetection reagents.
  • Arista BiologicalscoreTechnology or IntegrationSupplier of infectious disease lateral flow assay reagents including West Nile Virus antigens for diagnostic kit manufacturing.
  • Vector BiolabscoreTechnology or IntegrationViral vector supplier providing products and services for gene delivery and CAR-T/CAR-NK research programs.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Fortis Life Sciences competitors and assessment

Company assessment

Direct peers

  • GenScript: Life sciences services and reagents company offering custom antibody development, recombinant proteins, gene synthesis, and CDMO services — directly comparable to Fortis's antibody development/manufacturing services and AbNano VHH library offerings.
  • Abcam: Pure-play antibody supplier with a catalog of primary antibodies, conjugates, and immunoassay reagents serving biopharma, academic, and diagnostics customers. Most directly comparable to Fortis's Bethyl/Abcore franchises on product, customer base, and distribution model.
  • Cell Signaling Technology: Specialist antibody company focused on validated reagents for signal transduction, immuno-oncology, and IHC/WB applications — closely comparable to the Bethyl recombinant monoclonal antibody portfolio and the Fortis Six Pillars validation methodology positioning.
  • MilliporeSigma (Life Science): Life science arm of Merck KGaA offering antibodies, ELISA kits, enzymes, and reagents for research and applied markets — competes with Fortis across nearly every catalog category (antibodies, assay kits, enzymes, lateral-flow reagents).
  • Sino Biological: Recombinant antibody and protein manufacturer serving research, diagnostic, and biopharma customers globally — comparable in catalog breadth across recombinant antibodies/antigens and in supplying bulk/OEM to diagnostic kit manufacturers, similar to Fortis's CDMO and bulk reagent streams.
  • Bio-Techne: Global reagents and proteins company with leading antibody (R&D Systems, Novus Biologicals), ELISA, and proteomics franchises — directly competes with Fortis/Bethyl/Abcore in research-grade antibodies and assay kits, and shares the CDMO-adjacent reagent value proposition.
  • Santa Cruz Biotechnology: Long-standing research antibody supplier with broad primary and secondary antibody coverage for WB, IHC, IP, and ICC — competes head-to-head with Fortis/Bethyl/Abcore in academic and applied-research reagent purchasing.
  • Rockland Immunochemicals: Privately held antibody and immunoassay reagent supplier offering custom antibody development and OEM diagnostic reagents — closely comparable in product mix (WB/IHC antibodies, ELISA, OEM supply) and in target customer base of academic and diagnostic-OEM accounts.

Broad incumbents

  • Danaher (Life Sciences & Diagnostics): Diversified life sciences and diagnostics conglomerate housing Abcam, Cytiva, Beckman Coulter, Leica Biosystems, and Cepheid — competes with Fortis through its antibody subsidiary (Abcam) and across diagnostic reagent/CDMO adjacencies, with vastly greater resources and breadth.
  • Thermo Fisher Scientific: Largest life sciences tools incumbent offering antibodies (Invitrogen), ELISA, enzymes, viral vectors, and diagnostic manufacturing services through its Patheon CDMO franchise — overlaps Fortis across both product catalog and CDMO services but at much greater scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Fortis Life Sciences social profiles

Digital presence

Fortis Life Sciences compliance and trust

Trust signal

Compliance2 records

Fortis Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fortis Life Sciences leadership team

Management profile

Number of profiles

Fortis Life Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Fortis Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fortis Life Sciences M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fortis Life Sciences

What does Fortis Life Sciences do?

Fortis Life Sciences manufactures and supplies life science reagents and diagnostic components, including antibodies, antigens, ELISA kits, Western blot and IHC antibodies, clinical immunology reagents, enzymes, master mixes, lateral flow assay reagents, engineered nanoparticles, VHH single-domain antibody libraries, and viral vectors. The company also provides custom services spanning antibody development and manufacturing, diagnostic CDMO manufacturing, and spatial biology multiplex imaging, serving biopharma, diagnostics, research, and applied technology customers across 60+ countries.

Is Fortis Life Sciences a public or private company?

Fortis Life Sciences is a private company. It is classified as unknown and is currently operating.

When was Fortis Life Sciences founded?

Fortis Life Sciences was founded in 2020. It employs 101 to 250 people.

Where is Fortis Life Sciences based?

Fortis Life Sciences is headquartered in Boston, United States, in the North America region.

How does Fortis Life Sciences make money?

Three revenue lines are on record. Product Sales are the primary driver. The others are custom Services and bulk & OEM Supply.

Who are Fortis Life Sciences's main competitors?

Direct peers on record are GenScript, Abcam, Cell Signaling Technology, MilliporeSigma (Life Science), Sino Biological, Bio-Techne, Santa Cruz Biotechnology and Rockland Immunochemicals. Broad incumbents are Danaher (Life Sciences & Diagnostics) and Thermo Fisher Scientific.

Does Fortis Life Sciences have an API?

No public API is recorded for Fortis Life Sciences.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireFortis Life Sciences erweitert sein AbNano®-Portfolio um die erste VHH-Bibliothek, die aus peripheren natürlichen Killerzellen gewonnen wurde und der schnellen Antikörperentwicklung dientFortis Life Sciences announced the launch of the AbNano® VHH Anti-NK-Cell Library, the first single-domain antibody library derived from peripheral natural killer cells, designed to support translational and therapeutic research targeting complex NK-associated receptor systems. Internal validation studies identified binding sites at multiple NK-associated target molecules including CD56, CD8a, and NKp46. The new library, available as a standalone research product or as part of customized VHH discovery services, marks the third addition to the company's growing AbNano® portfolio.GlobeNewswireFortis Life Sciences enrichit son portefeuille AbNano® avec la première bibliothèque VHH dérivée de cellules tueuses naturelles périphériques pour accélérer la découverte d’anticorpsFortis Life Sciences announced the launch of its AbNano® VHH anti-NK cell library, described as the first of its kind derived from peripheral natural killer cells, designed to support translational and therapeutic programs targeting complex NK cell receptor systems. The library, developed from biologically relevant source material with strong sequential and structural diversity, enables identification of ligands against multiple NK-associated targets including CD56, CD8a and NKp46. This launch marks the third extension of the growing AbNano® portfolio, available both as a standalone research product and through customized VHH discovery services.GlobeNewswireFortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicamentsFortis Life Sciences has awarded Deliver Biosciences the first grant under the Fortis Grant Series 2026, providing access to AbNano VHH Discovery antibody services for targeted drug delivery research. The grant will support Deliver Biosciences' work on in vivo CAR-T therapies and gene therapy platforms aimed at treating conditions including HIV, sickle cell disease, and neurodegenerative disorders. Deliver Biosciences, which is developing nanoparticle-based delivery vectors to transport therapeutic cargo to specific in vivo cells, will use the services to advance its lead candidate toward clinical phase.GlobeNewswireFortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten WirkstoffabgabeFortis Life Sciences announced Deliver Biosciences as the winner of the 2026 AbNano VHH Discovery Grant, awarding the biotechnology company access to AbNano's single-domain antibody discovery services for targeted drug delivery research. Deliver Biosciences, which is developing in vivo CAR-T therapies and nanoparticle-based drug delivery vectors targeting diseases including HIV, sickle cell anemia, and neurodegenerative disorders, was selected from a global pool of applicants based on scientific quality, innovation, feasibility, and long-term impact. The grant aims to support researchers and drug developers in overcoming biological barriers that conventional antibodies cannot penetrate, particularly in dense tissues like solid tumors.GlobeNewswireFortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery ResearchFortis Life Sciences has awarded Deliver Biosciences the inaugural 2026 AbNano VHH Discovery Grant, providing the biotechnology company with access to specialized antibody discovery services. Deliver Biosciences plans to use the grant to advance its in vivo CAR-T and gene therapy programs targeting HIV, sickle cell disease, and neurodegenerative disorders. Fortis Life Sciences, established in 2020, evaluates grant applications globally based on scientific merit, innovation, and potential downstream impact in therapeutic development.InsideprecisionmedicineAdvances in Antibody Engineering for Therapeutic ApplicationsThe article reviews advancements in antibody engineering, highlighting the benefits of single-domain antibodies (VHH) and their applications in therapeutics such as bispecific antibodies, antibody-drug conjugates, and CAR-T cell therapies. It outlines how these technologies enhance targeting precision, stability, and efficacy in treating cancers, autoimmune disorders, and infectious diseases compared to traditional monoclonal antibodies. The content serves as an educational overview sponsored by Fortis Life Sciences to promote its research and development services.PR NewswireLEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET™ TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETINGBio-Techne Corporation announced that Lunaphore, its brand, will have its COMET™ spatial biology technology featured in multiple presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting in San Diego from November 1-5, 2023. Research institutes including Providence Cancer Institute's Earle A. Chiles Research Institute, A*STAR's Institute of Molecular Cell Biology, Massachusetts General Hospital, and Fortis Life Sciences will present data demonstrating COMET™'s hyperplex immunofluorescence capabilities for tumor microenvironment analysis and immunotherapy research. The presentations showcase the platform's ability to enable rapid seqIF™ panel development and high-throughput data analytics for advancing cancer therapy approaches.FortislifeFortis Life Sciences acquires International Point of CareFortis Life Sciences has acquired Toronto-based International Point of Care (IPOC) to create a customizable, end-to-end solution for the diagnostics industry. This acquisition adds IPOC's 36,000 sq. ft. GMP and ISO 13485 compliant manufacturing facility to Fortis' existing North American operations, enabling vertically integrated in-house manufacturing of diagnostic components.Medical BuyerFortis Life Sciences acquires International Point of CareFortis Life Sciences has acquired Toronto-based International Point of Care (IPOC), a developer and manufacturer of diagnostic components such as lyophilized reagents and membranes. This acquisition allows Fortis to offer end-to-end solutions for immunodiagnostic and molecular diagnostic products, adding IPOC's 36,000 sq. ft. facility to its North American manufacturing portfolio.FortislifeFortis Life Sciences Acquires Abcore, a Leader in Single-Domain Antibody TechnologiesFortis Life Sciences has acquired Abcore, a San Diego-based antibody discovery platform specializing in single-domain antibody technologies. This acquisition expands Fortis' capabilities into the VHH and antibody discovery market to serve biopharma customers developing therapeutic and diagnostic applications.